← Leaderboards
Changyi Chen
Emory University
$9,187,725
Attributed
$9,187,725
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$9,187,725 · 10
By mechanism
R01$7,837,063 · 6
T32$969,843 · 1
R21$365,819 · 1
R13$15,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Cheng-Kui Qu$14,877,721
- Paul W. Doetsch$10,204,007
- Boi-Hanh V. Huynh$2,283,113
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureEnzyme ActivityMacaca MulattaNitric OxideVascular EndotheliumProtease InhibitorMolecularGene ExpressionVasodilationBiological Signal TransductionEndothelinEnzyme Linked Immunosorbent AssayRitonavirSuperoxide DismutaseCardiovascular PharmacologyPeroxynitritesSurgeonNitric Oxide SynthaseClinical ResearchAscorbateAntiaids AgentNorthern BlottingsCell ProliferationHuman Subject
Grant awards (35)
Natural Substance Derivative DHNB is A Novel Xanthine Oxidase Inhibitor$199,538
R21 · FY2014 · AR · contact PI
Natural Substance Derivative DHNB is A Novel Xanthine Oxidase Inhibitor$166,281
R21 · FY2013 · AR · contact PI
Molecular Surgeon Research Training on Vascular Disease$132,411
T32 · FY2012 · HL · contact PI
Molecular Surgeon Research Training on Vascular Disease$244,166
T32 · FY2011 · HL · contact PI
Molecular Surgeon Research Training on Vascular Disease$240,123
T32 · FY2010 · HL · contact PI
Effects of HAART drugs on endothelial dysfunction of pu*$355,568
R01 · FY2009 · HL · contact PI
Molecular Surgeon Research Training on Vascular Disease$238,136
T32 · FY2009 · HL · contact PI
Effects of HAART drugs on endothelial dysfunction of pu*$355,568
R01 · FY2008 · HL · contact PI
Molecular Surgeon Research Training on Vascular Disease$115,007
T32 · FY2008 · HL · contact PI
Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer$5,000
R13 · FY2008 · CA · contact PI
Effects of HAART drugs on endothelial dysfunction of pu*$355,568
R01 · FY2007 · HL · contact PI
Tissue engineering of small diameter vascular graft$432,815
R01 · FY2006 · EB · contact PI
Effects of HAART drugs on endothelial dysfunction of pu*$366,188
R01 · FY2006 · HL · contact PI
Tissue engineering of small diameter vascular graft$430,319
R01 · FY2005 · EB
Effects of HAART drugs on endothelial dysfunction of pu*$375,000
R01 · FY2005 · HL
Effects of HIV Protease Inhibitors of Endothelial Barrie$301,000
R01 · FY2005 · HL
Molecular Surgeon Symposium on Vascular Injury, Repair$10,000
R13 · FY2005 · HL
Tissue engineering of small diameter vascular graft$493,483
R01 · FY2004 · EB
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$370,858
R01 · FY2004 · HL
Effects of HIV Protease Inhibitors of Endothelial Barrie$301,000
R01 · FY2004 · HL
Tissue engineering of small diameter vascular graft$485,457
R01 · FY2003 · EB
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$370,058
R01 · FY2003 · HL
Effects of HIV Protease Inhibitors of Endothelial Barrie$301,000
R01 · FY2003 · HL
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$366,571
R01 · FY2002 · HL
HIV/SIV ENVELOPE GLYCOPROTEIN EFFECTS ON ENDOTHELIA$301,000
R01 · FY2002 · HL
Effects of HIV Protease Inhibitors of Endothelial Barrie$301,000
R01 · FY2002 · HL
ANGIOTENSIN II AND REGULATION OF MCP-1 GENE EXPRESSION$110,636
R01 · FY2002 · HL
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$338,004
R01 · FY2001 · HL
HIV/SIV ENVELOPE GLYCOPROTEIN EFFECTS ON ENDOTHELIA$255,665
R01 · FY2001 · HL
HIV/SIV ENVELOPE GLYCOPROTEIN EFFECTS ON ENDOTHELIA$50,787
R01 · FY2001 · HL
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$32,750
R01 · FY2001 · HL
HIV PROTEASE INHIBITORS EFFECT--NENDOTHELIAL DYSFUNCTION$370,310
R01 · FY2000 · HL
HIV/SIV ENVELOPE GLYCOPROTEIN EFFECTS ON ENDOTHELIA$309,000
R01 · FY2000 · HL
ANGIOTENSIN II AND REGULATION OF MCP-1 GENE EXPRESSION$58,993
R01 · FY2000 · HL
ANGIOTENSIN II AND REGULATION OF MCP-1 GENE EXPRESSION$48,465
R01 · FY2000 · HL